KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

The preliminary data was accepted as a late breaking abstract.If...

  1. Rinnekin
    114 Posts.
    lightbulb Created with Sketch. 125
    clock Created with Sketch.
    05/10/23
    10:44
    Post #: 70184098
    The preliminary data was accepted as a late breaking abstract.
    If it did not include efficacy results the scientific world needs to know about, it would not fulfil the criteria in this category.
    All current study arms in the DIPG combo PNOC trial include paxalisib and ONC201 in different treatment patterns.
    KZA Price at posting: 16.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch. 5  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
FHE Frontier Energy lines up $215 million debt financing from Mike Cannon-Brookes-backed Infradebt
right-arrow Created with Sketch.
TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.